Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438371 · ClinicalTrials.gov registry record · Phase 4
Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT02438371 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 49 participants.
The verdict
NCT02438371, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
Tocolytic agents are used for the treatment of preterm labor. It is unclear whether combination treatments of two tocolytic agents are more effective in stopping preterm labor compared to one. Therefore, the investigators propose a comparative effective trial of nifedipine plus indomethacin vs. nifedipine alone for the treatment of preterm labor
Interventions
- DRUG Indomethacin
- DRUG Nifedipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-10-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438371
The ClinicalTrials.gov registry entry for NCT02438371 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin is the first listed.
NCT02438371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438371 about?
NCT02438371 is a clinical study titled "Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor". Tocolytic agents are used for the treatment of preterm labor. It is unclear whether combination treatments of two tocolytic agents are more effective in stopping preterm labor compared to one. Therefore, the investigators propose a comparative effective trial of nifedipine plus indomethacin vs. nife...
What is the current status of trial NCT02438371?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2015-05. Estimated completion is 2019-10-10.
What interventions are being tested in trial NCT02438371?
The interventions under investigation include: Indomethacin (DRUG), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT02438371?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.